Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy.

Purpose: We hypothesized that intraoperative preplanning for transperineal interstitial permanent prostate brachytherapy may yield better prostate cancer control than preoperative preplanning. We tested this hypothesis by comparing treatment outcomes of patients who underwent implantation using thes...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancer Journal Vol. 12; no. 4; pp. 289 - 298
Autores principales: Shah JN, Wuu CS, Katz AE, Laguna JL, Benson MC, Ennis RD, Shah, Jinesh N, Wuu, Cheng-Shie, Katz, Aaron E, Laguna, Joseph L, Benson, Mitchell C, Ennis, Ronald D
Formato: research Journal Article
Publicado: Lippincott Williams & Wilkins Jul/Aug2006
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106019085&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106019085
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15289117
        4U5
      jtl: Cancer Journal
      issn: 15289117
      maglogo: N
    pubinfo:
      dt: Jul/Aug2006
      vid: 12
      iid: 4
      pid: 5086
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        106019085
        106019085
        NLM16925973
        2009277144
        10.1097/00130404-200607000-00007
        NLM16925973
        106019085
      ppf: 289
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy.
      aug:
        au:
          Shah JN
          Wuu CS
          Katz AE
          Laguna JL
          Benson MC
          Ennis RD
          Shah, Jinesh N
          Wuu, Cheng-Shie
          Katz, Aaron E
          Laguna, Joseph L
          Benson, Mitchell C
          Ennis, Ronald D
        affil: Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, New York, New York 10019, USA
      sug:
        subj:
          Adenocarcinoma Radiotherapy
          Prostatic Neoplasms Radiotherapy
          Adenocarcinoma Surgery
          Brachytherapy
          Intraoperative Period
          Male
          Prognosis
          Prospective Studies
          Prostatic Neoplasms Surgery
          Radiation Dosage
          Radiotherapy, Computer-Assisted
          Human
          Male
      ab: Purpose: We hypothesized that intraoperative preplanning for transperineal interstitial permanent prostate brachytherapy may yield better prostate cancer control than preoperative preplanning. We tested this hypothesis by comparing treatment outcomes of patients who underwent implantation using these two preplanning methods.Patients and Methods: We analyzed the data of 135 consecutive patients with localized prostate cancer treated from 1996 to 2001 with transperineal interstitial permanent prostate brachytherapy+/-preimplantation hormonal therapy: 42 received preoperative preplanning (group 1), and 93 underwent intraoperative preplanning (group 2). Biochemical status was assessed using two failure definitions: American Society for Therapeutic Radiology and Oncology (ASTRO) (three consecutive rises in prostate-specific antigen level) and Houston (prostate-specific antigen level>or=current nadir+2 ng/mL). Clinical disease-free survival and postimplantation dosimetry were also examined.Results: All disease control outcomes were superior for group 2. The 4-year ASTRO biochemical no evidence of disease rate was 80% for group 1 versus 94% for group 2. The 4-year Houston biochemical no evidence of disease rate was 82% for group 1 versus 96% for group 2. The 4-year clinical disease-free survival rate was 87% for group 1 versus 99% for group 2. Preplanning method (preoperative versus intraoperative) remained predictive of disease control outcomes in multivariate analyses with the covariates of pretreatment prostate-specific antigen level, Gleason score, clinical stage, and case sequence number (proxy for brachytherapist experience and "stage migration"). Dosimetric prostate coverage was superior for group 2. The mean percentage of the prescription dose delivered to 90% of the prostate volume (%D90) was 75% for group 1 versus 90% for group 2. A %D90>or=70% predicted for improved disease control; fewer group 1 than 2 patients met this dosimetric criterion (55% versus 87%).Discussion: Intraoperative preplanning yielded superior disease control outcomes in this analysis, likely due at least in part to improved dosimetric prostate coverage with this method. Although not mandatory for obtaining high prostate brachytherapy efficacy, intraoperative preplanning nevertheless may offer an excellent means of improving dosimetric prostate coverage and therefore disease control outcomes.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N